medigraphic.com
Academia Mexicana de Neurología, A.C.

2006, Number 6

<< Back Next >>

Rev Mex Neuroci 2006; 7 (6)

Bony complications in medular spinal injured

Barnés DJA

Language: Spanish
References: 29
Page: 592-595
PDF size: 62.45 Kb.


ABSTRACT

We carry out a revision of the bony complications in the one injured medullary spinal with relationship to the epidemic, biochemical, clinical, radiological and therapeutic aspects.


REFERENCES

  1. Mazaira J, Labanda F, Romero J, García ME, et al. Epidemiología de la lesión medular y otros aspectos. Rehabilitación. Madrid 1998; 32: 365-72.

  2. Garcés RC, Civera OA. Lesión en la médula espinal. Actuación de enfermería. Rev Rol Enf 1997; 20(230): 21-2.

  3. Barnés DJA, et al. Lesión medular traumática. Rev Mexicana de Neurociencia 2003; 4(1): 21-5.

  4. Barnés Domínguez JA, et al. Alteraciones radiológicas en el lesionado medular. Rev Mexicana de Neurociencia 2002; 3(5): 261-5.

  5. Riggs B, Melton U. The prevention and treatment of osteoporosis. N England J Med 1992; 327: 620-7.

  6. Melton U, Chrischilles EA, Cooper C, Lane AW, Rigs BL. How many people have osteoporosis. J Bone Miner Res 1992; 7: 1005-10.

  7. Looker AC, Johnston CCJr, Wahner HW, Dunn WL, Calvo SM, Harris TB, et al. Prevalence of low femoral bone density in older US, women from NHANES III. J Bone Miner Res 1995; 10: 796-802.

  8. Melton LJ. How many women have osteoporosis now. Bone Miner Res 1995; 10: 175-7.

  9. Consensus Development Conference. Prophylaxis and treatment of osteoporosis. Am J Med 1991; 90: 107-10.

  10. Demirel G, Yilmaz H, Paker N, Onel S. Osteoporosis after spinal cord injury. Spinal Cord 1998; 36(12): 822-5.

  11. Baluja Conde I, Rodríguez Chaufrau J, Baluja Conde IB. Factores bioquímicos involucrados en el origen y desarrollo de la osteoporosis: I Parte. Bioquimia 1998; 23(4): 899-903.

  12. Garnero P, et al. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to Alendronate treatment. J. Clin Endocrinol Metab 1994; 79(6): 1693-700.

  13. Price PA. Vitamin K-despondent bone protein. In: Cohn DV, Martín TJ, Meunier PJ (eds.). Calcium regulation and bone metabolism: Basic and clinical aspects. Vol. 9. New York: Elsevier; 1987, p. 419-26.

  14. Zamora PF, et al. Marcadores bioquímicos del metabolismo óseo en la osteoporosis del lesionado medular. Revisión bibliográfica. Rev cubana de Farmacia 2001; 35(Supl. especial): 424-6.

  15. Biering Sorense F, et al. Longitudinal study of bone mineral content in the lumbar spine, the forearm and lower extremeties after spinal cord injury. Eur J Clin Invest 1995; 240-7.

  16. Fogelman I, Ryan P. Measurements of bone mass. Bone 1992; 13: 23-8.

  17. Kanis JA, et al. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9: 1137-40.

  18. Reyes LlAG. Osteoporosis: Impacto socioeconómico e importancia de establecer programas de prevención e intervención a nivel mundial. Rev Cub Reumatol 1999; 1(1): 4-9.

  19. Lane NY. Osteoporosis: A critical evaluation. Rheumatology Grand Rounds 1999; 2(2): 1-7.

  20. Rosier RN. Expanding the role of the orthopaedic surgeon in the treatment of osteoporosis. Clin Orthopaed Relat Research 2001; 385: 57-67.

  21. Chantraine A, Nusgens B, Lapiere CM. Biochemical analysis of heterotopic ossification in spinal cord injury patients. Paraplegia 1995; 33: 398-401.

  22. Banovac K, González F. Evaluation and management of heterotopic ossification in patients with spinal cord injury. Spinal Cord 1997; 35: 158-62.

  23. Freebourn TM, Barber DB, Able AC. The treatment of immature heterotopic ossification in spinal cord injury with combination surgery, radiation therapy and NSAID. Spinal Cord 1999; 37: 50-3.

  24. Restrepo R, et al. Rehabilitación de la persona con lesión medular. Rehabilitación en Salud: Una mirada médica necesaria. Universidad de Antioquia, Colombia: 1995; 240-7.

  25. Shehab D, Elgazzar AH, Collier BD. Heterotopic Ossification. J Nucl Med 2002; 43(3): 346-53.

  26. Taly AB, Nair KPS, Veerendra KM, et al. Heterotopic ossification in non-traumatic myelopathies. Spinal Cord 1999; 37: 47-9.

  27. Dai L. Heterotopic ossification of the hip after spinal cord injury. Chin Med J 1998; 111(12): 1099-101.

  28. Banovac K, Williams JM, Patrick LD, Haniff YM. Prevention of heterotopic ossification after spinal cord injury with indomethacin. Spinal Cord 2001; 39(7): 370-4.

  29. Banovac K, González F, et al. Intravenous disodium etidronate therapy in spinal cord injury patients with heterotopic ossification. Paraplegia 1993; 31: 660-6.




2020     |     www.medigraphic.com